Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study

Abstract

These population-based data suggest that the use of biologics by women with autoimmune diseases during pregnancy is not associated with an increased risk of serious infections in mothers, during post partum or in infants during the first year of life.